跳至主要内容
临床试验/IRCT201702012266N6
IRCT201702012266N6已完成3 期

Assessment of adding Pregabalin to daily treatment regimen in reducing withdrawal symptoms in opioid dependent patients

Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • being drug dependent based on DSM-V criteria; regular oral/smoking daily consumption of opium; using no other medication including psychiatric drugs and also other substances except cigarette; not using pain medications; absence of other comorbid psychiatric disorders; not having any special diseases in which addiction treatment is prohibited; no contraindication for pregabalin consumption; no use of any other medication interacting with pregabalin.
  • Exclusion criteria: lack of patients' interest for participation in the study.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Isfahan University of Medical Sciences

相似试验